Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0001430 (
adenoma
)
21,222
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Genetic variants in bitter-taste receptor genes have been hypothesized to negatively impact health outcomes and/or influence dietary intake and, consequently, could increase the risk of colorectal neoplasia. Using a case-control study of 914 colorectal
adenoma
cases/1188 controls, we explored associations among colorectal
adenoma
risk, dietary intake, and genetic variation in 3 bitter-taste receptor genes: TAS2R38 (rs713598, rs1726866, rs10246939), TAS2R16 (rs846672), and
TAS2R50
(rs1376251). Analysis of covariance was conducted to detect trends in dietary intake across TAS2R genotypes/haplotypes. Odds ratios and 95% confidence intervals were estimated by logistic regression to test gene-
adenoma
risk associations. No significant associations were observed between the TAS2R38 PAV/PAV diplotype or the TAS2R16 (rs846672) polymorphism with the selected diet variables. We observed weak inverse associations between the
TAS2R50
(rs1376251) C allele and dietary fiber and vegetable intake (Ps < 0.015). Odds ratios for
adenoma
risk were not significantly different from the null. Our findings do not support a link between these TAS2R genotypes/haplotypes and dietary intake that could impact colorectal
adenoma
risk. However, given the paucity of data, we cannot dismiss the possibility that these genes may influence colorectal
adenoma
risk in other ways, such as through impaired gastrointestinal function, particularly in subgroups of the population.
...
PMID:Variations in bitter-taste receptor genes, dietary intake, and colorectal adenoma risk. 2408 39